Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Taramasso

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
Infectious Diseases and Therapy|November 29, 2024
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro TrialBarbara Rossetti, Micol Ferrara, Lucia Taramasso, et al.
Journal of Medical Virology|October 8, 2023
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort studyFilippo Lagi, Andrea Giacomelli, Vanni Borghi, et al.
Journal of Medical Virology|February 9, 2023
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patientsGiulia Ciccarese, Antonio Di Biagio, Bianca Bruzzone, et al.
AIDS Research and Human Retroviruses|February 17, 2022
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIVLucia Taramasso, Sergio Lo Caputo, Laura Magnasco, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2022
Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian centerGiorgio Bozzi, Paola Saltini, Malvina Matera, et al.
Infection|April 7, 2016
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY studyGiuseppe Vittorio De Socio, Elena Ricci, Giustino Parruti, et al.
Viruses|January 8, 2025
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 PandemicAlessandra Vergori, Nicola Gianotti, Alessandro Tavelli, et al.
AIDS (London, England)|August 30, 2024
Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIVLucia Taramasso, Chiara Dentone, Isabella Cama, et al.
AIDS Research and Therapy|August 28, 2019
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)Lucia Taramasso, Elena Ricci, Antonio Cascio, et al.
Frontiers in Medicine|January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
Infectious Diseases and Therapy|November 29, 2024
Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro TrialBarbara Rossetti, Micol Ferrara, Lucia Taramasso, et al.
Journal of Medical Virology|October 8, 2023
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort studyFilippo Lagi, Andrea Giacomelli, Vanni Borghi, et al.
Journal of Medical Virology|February 9, 2023
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patientsGiulia Ciccarese, Antonio Di Biagio, Bianca Bruzzone, et al.
AIDS Research and Human Retroviruses|February 17, 2022
Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIVLucia Taramasso, Sergio Lo Caputo, Laura Magnasco, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 14, 2022
Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian centerGiorgio Bozzi, Paola Saltini, Malvina Matera, et al.
Infection|April 7, 2016
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY studyGiuseppe Vittorio De Socio, Elena Ricci, Giustino Parruti, et al.
Viruses|January 8, 2025
Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 PandemicAlessandra Vergori, Nicola Gianotti, Alessandro Tavelli, et al.
AIDS (London, England)|August 30, 2024
Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIVLucia Taramasso, Chiara Dentone, Isabella Cama, et al.
AIDS Research and Therapy|August 28, 2019
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)Lucia Taramasso, Elena Ricci, Antonio Cascio, et al.
Frontiers in Medicine|January 26, 2023
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19Federico Baldi, Chiara Dentone, Malgorzata Mikulska, et al.
Pageof 14